查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1873337

全球醫院感染控制市場

Hospital Acquired Infection Control
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 246 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球醫院感染控制市場預計到2030年將達到351億美元

全球醫院感染控制市場預計在2024年達到307億美元，預計到2030年將達到351億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為2.2%。本報告分析的細分市場之一－防護屏障，預計複合年成長率為2.0%，到分析期末將達到111億美元。消毒設備細分市場預計在分析期間內複合年成長率為2.5%。

美國市場規模估計為83億美元，而中國市場預計將以3.0%的複合年成長率成長。

據估計，2024年美國醫院感染控制市場規模將達83億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到65億美元，在2024年至2030年的分析期間內，年複合成長率（CAGR）為3.0%。其他值得關注的區域市場分析包括日本和加拿大，預計兩國在分析期間的年複合成長率為1.9%。在歐洲，德國預計年複合成長率約為1.9%。

全球醫院感染控制市場－主要趨勢與促進因素概述

醫院感染控制是營造更安全醫療環境的關鍵嗎？

醫院感染（HAI）是醫療機構面臨的一大難題，但為什麼感染控制對病人安全如此重要？醫院感染是指患者在醫院或其他醫療機構接受治療期間發生的新的感染。這些感染包括肺炎、手術部位感染、血流感染和尿道感染，通常由細菌、病毒或真菌引起。有效的感染控制措施對於限制這些感染的傳播和保護易感患者至關重要。

感染控制的重要性在於其能夠預防危險病原體在醫療環境中的傳播。若缺乏嚴格的通訊協定，醫院感染會導致住院時間延長、醫療成本增加，嚴重時甚至會危及生命或導致死亡。隨著抗藥性細菌的出現，採取有效的感染預防措施變得更加迫切。感染控制措施有助於維持更清潔的環境、改善患者預後並限制抗藥性病原體的傳播，因此是現代醫療保健系統不可或缺的一部分。

科技如何促進了醫院感染控制？

科技進步顯著提升了醫院感染控制的工具和方法，使感染預防更加有效。其中最具影響力的進展之一是紫外線 (UV) 消毒系統的應用。 UV-C 紫外線用於醫療環境中的表面和空氣消毒，殺滅傳統清潔方法無法去除的病原體。這些系統廣泛應用於手術室、加護病房(ICU) 和病房，為預防醫院感染提供了額外的保護。

自動化手衛生監測系統是另一項提升感染控制效果的創新技術。這些系統能夠追蹤和監測醫護人員的手部衛生遵從性，幫助確保他們遵守正確的衛生通訊協定。手部衛生是預防感染傳播最有效的方法之一，而自動化監測可以提供即時數據，以便在依從率下降時及時採取干涉措施。

先進的診斷技術和即時監測工具也徹底改變了醫院的感染控制方法。病原體的快速診斷檢測能夠及早發現感染，使受感染的患者能夠更快地得到治療和隔離。數位化平台和人工智慧驅動的分析能夠追蹤醫院內的感染模式，並提供預測潛在疫情爆發的洞察。這些工具可協助感染控制團隊識別高風險區域，並制定有針對性的措施來阻止感染的傳播。

滅菌技術也在不斷發展，提高了醫療設備和儀器的安全性。低溫滅菌方法，例如過氧化氫蒸氣和等離子滅菌，能夠有效消毒對熱敏感的設備，確保手術器械和醫療設備不含任何有害病原體。這些技術對於感染風險較高的侵入性手術中使用的器械尤其重要。

抗菌表面的研發為感染控制增添了一層額外的保護。研究表明，塗覆銅、銀等材料的表面能夠抑制醫療環境中細菌和其他病原體的生長和傳播。這些抗菌表面正擴大應用於床欄、門把手和醫療設備等高頻接觸區域，以降低因表面接觸而導致的醫院感染風險。

為什麼醫院感染控制對病人安全和醫療效率至關重要？

醫院感染控制對於保障病人安全、降低醫療成本以及維持整個醫療系統的高效運作至關重要。醫院感染可能對患者健康造成嚴重後果，尤其是免疫力較弱、患有慢性疾病、術後復原的患者。有效的感染控制能夠預防病原體的傳播，保護脆弱的患者免受危及生命的感染疾病，從而避免阻礙他們的治療和復原。

除了保護患者健康外，感染控制措施還有助於預防抗藥性細菌的傳播，例如抗藥性金黃色葡萄球菌(MRSA) 和耐碳青黴烯類腸桿菌 (CRE)。這些超級細菌難以治療，可能導致嚴重的併發症、延長住院時間，甚至死亡。感染控制措施，例如正確的手部衛生、使用個人防護設備(PPE) 和嚴格的清潔程序，有助於限制這些危險病原體在醫療機構內的傳播。

感染控制也能透過降低醫療相關感染（HAI）的發生率來提高醫療效率。管理HAI需要耗費大量成本和資源。感染HAI的患者通常需要額外的醫療護理，包括更長的住院時間、更頻繁的就診以及更昂貴的藥物。這會給醫療機構帶來更大的壓力，並增加醫院和病人的成本。透過降低感染率，醫院可以最佳化資源配置，降低病患再入院率，並改善整體醫療效果。

感染控制的另一個重要面向是保護醫護人員免受傳染性病原體的侵害。由於醫護人員經常接觸血液、體液和受污染的表面，他們面臨感染風險。適當的感染控制通訊協定，包括個人防護設備（PPE）、表面消毒和疫苗接種計劃，可以保護醫護人員，使他們能夠在不危及自身或他人安全的情況下繼續提供醫療服務。

哪些因素正在推動醫院感染控制市場的成長？

由於醫院感染（HAI）發生率上升、人們對感染控制措施的認知不斷提高以及醫療技術的進步等幾個關鍵因素，醫院感染控制市場正經歷顯著成長。其中一個主要促進因素是全球範圍內醫院感染的日益普遍。隨著醫療機構收治的複雜疾病患者越來越多，醫院環境中感染傳播的風險也增加。這促使醫院投資更有效的感染控制措施，例如紫外線消毒系統和先進的監測工具。

人們對感染預防重要性的認知不斷提高，尤其是在新冠肺炎疫情等全球健康挑戰的背景下，也推動了感染控制技術的應用。各國政府、醫療機構和監管機構更加重視提升感染控制標準，許多國家實施了更嚴格的法規以降低醫院感染率。民眾對醫院安全的關注也不斷提高，這促使人們更加重視醫院在感染預防方面的投入。

消毒和滅菌製程的技術進步也推動了市場成長。諸如紫外線C波段和過氧化氫蒸氣系統等新型消毒技術正變得越來越普及，並被全球醫療機構迅速採用。這些技術能夠比傳統清潔方法更快、更徹底地消毒，進而降低病原體傳播的風險。同樣，抗菌表面和先進個人防護設備（PPE）的廣泛應用也有助於保障醫護人員和病患免受感染。

推動市場成長的另一個因素是醫療基礎設施投資的增加，尤其是在新興市場。隨著開發中國家醫療體系的擴展，對符合國際醫療標準的感染控制產品和服務的需求日益成長。這些地區的許多醫療機構正在更新設備和通訊協定，以提高病人安全並防止醫院感染的傳播。

最後，人們對病人安全和醫療品質日益成長的關注，正推動更先進的感染控制措施的採用。醫院面臨越來越大的壓力，需要達到認證標準並保持較低的感染率，以吸引患者並維護自身聲譽。包括即時監測、先進診斷技術和自動化消毒系統在內的感染控制系統，正成為實現這些目標的關鍵工具。

由於對感染預防技術​​的需求不斷成長、醫療基礎設施的進步以及人們對醫院感染風險的認知不斷提高，醫院感染控制市場預計將快速擴張。隨著醫療機構將病人安全和效率放在首位，感染控制措施將繼續在預防醫院感染、確保病人和醫護人員的健康方面發揮核心作用。

部分：

依產品（防護屏障、消毒設備、消毒劑、其他產品）、依應用（醫院/加護病房、門診手術/診斷中心、療養院/婦產中心、其他應用）分類

受訪公司範例

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB（Getinge Group）
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Global Industry Analysts 並沒有依賴通用的 LLM 或查詢產業專用的SLM，而是建立了一個由世界各地領域專家精心整理的內容庫，包括視訊轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

我們最新發布的報告納入了關稅對區域市場的影響，正如全球產業分析師預測的那樣，關稅將改變企業的競爭地位，而企業的競爭地位將取決於其總部所在地、製造地以及進出口（成品和OEM產品）。這種複雜多變的市場現實將透過微觀和宏觀市場動態影響競爭對手，包括銷貨成本增加、盈利下降以及供應鏈重組。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP12430

Global Hospital Acquired Infection Control Market to Reach US$35.1 Billion by 2030

The global market for Hospital Acquired Infection Control estimated at US$30.7 Billion in the year 2024, is expected to reach US$35.1 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Protective Barrier, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Sterilization Equipment segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.3 Billion While China is Forecast to Grow at 3.0% CAGR

The Hospital Acquired Infection Control market in the U.S. is estimated at US$8.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 3.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Hospital Acquired Infection Control Market - Key Trends and Drivers Summarized

Is Hospital Acquired Infection Control the Key to Safer Healthcare Environments?

Hospital-acquired infections (HAIs) are a significant concern in healthcare settings, but why is infection control so crucial for patient safety? Hospital-acquired infections occur when patients develop new infections while receiving care in hospitals or other medical facilities. These infections include conditions such as pneumonia, surgical site infections, bloodstream infections, and urinary tract infections, often caused by bacteria, viruses, or fungi. Effective infection control measures are essential for reducing the spread of these infections and protecting vulnerable patients.

The importance of infection control lies in its ability to prevent the transmission of dangerous pathogens within healthcare environments. Without stringent protocols, HAIs can prolong hospital stays, increase healthcare costs, and, in severe cases, lead to life-threatening conditions or death. With the rise of antibiotic-resistant organisms, the need for effective infection prevention measures has become more urgent. Infection control practices help maintain cleaner environments, improve patient outcomes, and reduce the spread of drug-resistant pathogens, making them a vital component of modern healthcare systems.

How Has Technology Advanced Hospital-Acquired Infection Control?

Technological advancements have significantly enhanced the tools and methods used for hospital-acquired infection control, making infection prevention more effective and efficient. One of the most impactful developments is the use of ultraviolet (UV) disinfection systems. UV-C light is used to sterilize surfaces and air in healthcare settings, killing pathogens that may otherwise remain after traditional cleaning. These systems have been widely adopted in operating rooms, intensive care units (ICUs), and patient rooms, providing an additional layer of protection against HAIs.

Automated hand hygiene monitoring systems are another innovation that has improved infection control efforts. These systems track and monitor hand hygiene compliance among healthcare workers, helping to ensure that proper sanitation protocols are followed. Hand hygiene is one of the most effective methods of preventing the spread of infections, and automated monitoring provides real-time data, allowing for timely interventions if compliance rates drop.

Advanced diagnostics and real-time surveillance tools have also transformed how hospitals manage infection control. Rapid diagnostic tests for pathogens allow for quicker identification of infections, enabling faster treatment and isolation of affected patients. Digital platforms and AI-driven analytics are used to track infection patterns within hospitals, providing insights into potential outbreaks before they occur. These tools help infection control teams identify high-risk areas and develop targeted interventions to stop the spread of infections.

Sterilization technologies have also evolved, improving the safety of medical equipment and tools. Low-temperature sterilization methods, such as vaporized hydrogen peroxide and plasma sterilizers, allow for the effective disinfection of heat-sensitive equipment, ensuring that surgical instruments and medical devices are free from harmful pathogens. These technologies are especially important for devices used in invasive procedures, where the risk of infection is higher.

The development of antimicrobial surfaces has added another layer of protection in infection control. Surfaces coated with materials like copper or silver have been shown to reduce the growth and spread of bacteria and other pathogens in healthcare environments. These antimicrobial surfaces are increasingly being used on high-touch areas like bed rails, door handles, and medical equipment, reducing the risk of HAIs through surface contact.

Why Is Hospital-Acquired Infection Control Critical for Patient Safety and Healthcare Efficiency?

Hospital-acquired infection control is critical for ensuring patient safety, reducing healthcare costs, and maintaining overall healthcare system efficiency. HAIs can severely impact patient health, particularly among those with weakened immune systems, chronic illnesses, or those recovering from surgery. Effective infection control measures prevent the transmission of pathogens, safeguarding vulnerable patients from potentially life-threatening infections that can complicate their treatment and recovery.

In addition to safeguarding patient health, infection control measures help prevent the spread of drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE). These superbugs are difficult to treat and can lead to severe complications, prolonged hospital stays, and even death. Infection control measures, such as proper hand hygiene, the use of personal protective equipment (PPE), and strict cleaning protocols, help limit the spread of these dangerous pathogens within healthcare facilities.

Infection control also improves healthcare efficiency by reducing the incidence of HAIs, which are costly and resource-intensive to manage. Patients who contract HAIs often require additional medical care, including extended hospital stays, more frequent doctor visits, and expensive medications. This increases the burden on healthcare facilities, leading to higher costs for both the hospital and the patient. By reducing infection rates, hospitals can optimize resource allocation, reduce patient readmission rates, and improve overall healthcare outcomes.

Another vital aspect of infection control is protecting healthcare workers from exposure to infectious agents. Healthcare workers are frequently exposed to blood, bodily fluids, and contaminated surfaces, putting them at risk for contracting infections. Proper infection control protocols, including PPE, surface disinfection, and vaccination programs, protect healthcare workers, ensuring they can continue to provide care without putting themselves or others at risk.

What Factors Are Driving the Growth of the Hospital-Acquired Infection Control Market?

The hospital-acquired infection control market is experiencing significant growth due to several key factors, including the rising incidence of HAIs, growing awareness of infection control measures, and advancements in healthcare technology. One of the primary drivers is the increasing prevalence of HAIs across the globe. As healthcare facilities treat more patients with complex medical needs, the risk of infections spreading in hospital settings has risen. This has prompted hospitals to invest in more effective infection control measures, from UV disinfection systems to advanced surveillance tools.

The rising awareness of the importance of infection prevention, particularly in light of global health challenges like the COVID-19 pandemic, has also driven the adoption of infection control technologies. Governments, healthcare institutions, and regulatory bodies are placing greater emphasis on improving infection control standards, with many countries implementing stricter regulations to reduce the incidence of HAIs. Public awareness of hospital safety has increased as well, leading to more demand for hospitals to demonstrate their commitment to infection prevention.

Technological advancements in disinfection and sterilization processes are also contributing to market growth. New disinfection technologies, such as UV-C and hydrogen peroxide vapor systems, have become more accessible and are being rapidly adopted in healthcare facilities worldwide. These technologies offer faster, more thorough disinfection than traditional cleaning methods, reducing the risk of pathogen transmission. Similarly, the rise of antimicrobial surfaces and advanced PPE is helping healthcare workers and patients stay safer from infections.

Another factor driving market growth is the increasing investment in healthcare infrastructure, particularly in emerging markets. As developing countries expand their healthcare systems, there is a growing need for infection control products and services to meet international healthcare standards. Many healthcare facilities in these regions are upgrading their equipment and protocols to improve patient safety and prevent the spread of HAIs.

Finally, the increasing focus on patient safety and quality care is influencing the adoption of more sophisticated infection control measures. Hospitals are under growing pressure to meet accreditation standards and demonstrate low infection rates to attract patients and maintain their reputations. Infection control systems, including real-time monitoring, advanced diagnostics, and automated disinfection, are becoming essential tools in achieving these goals.

With growing demand for infection prevention technologies, advancing healthcare infrastructure, and increasing awareness of the dangers posed by HAIs, the hospital-acquired infection control market is expected to expand rapidly. As healthcare facilities prioritize patient safety and efficiency, infection control measures will remain central to preventing HAIs and ensuring healthier outcomes for patients and healthcare workers alike.

SCOPE OF STUDY:

The report analyzes the Hospital Acquired Infection Control market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Protective Barrier, Sterilization Equipment, Disinfectants, Other Products); End-Use (Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB (Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Hospital Acquired Infection Control - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Expansion of Healthcare Infrastructure Spurs Adoption of Advanced HAI Control Measures
    • Growth in Hospital Admissions and Surgical Procedures Expands Addressable Market for HAI Control
    • Role of HAI Control in Enhancing Patient Safety and Reducing Healthcare Costs Strengthens Business Case for Adoption
    • Increasing Focus on Antimicrobial Resistance and Superbugs Fuels Market Demand for HAI Control Solutions
    • Growth in Use of Ultraviolet (UV) and Hydrogen Peroxide-based Disinfection Expands Market Opportunities
    • Technological Integration for Automated and Robotic Disinfection Systems Expands Market Potential
    • Growth in Demand for Single-use Medical Devices and Disposable Products Fuels Market Adoption
    • Increasing Focus on Hand Hygiene and Personal Protective Equipment (PPE) Expands Addressable Market
    • Growth in Use of Antimicrobial Coatings and Barrier Materials in Healthcare Settings Strengthens Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hospital Acquired Infection Control Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Protective Barrier by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sterilization Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Disinfectants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Ambulatory Surgery & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Nursing Homes & Maternity Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hospital Acquired Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hospital Acquired Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hospital Acquired Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hospital Acquired Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION